Some patients with COVID-19 will be able to get easier access to Pfizer's oral antiviral therapy Paxlovid, after the FDA ruled that pharmacists would be able to prescribe the drug.
Scientists have has pioneered antivirals targeting viral methyltransferases, offering a new strategy for treating RNA and DNA ...